Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.

[1]  Takashi Morita,et al.  Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate v , 2009, Journal of the American College of Cardiology.

[2]  P. Camici,et al.  123I-mIBG Scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: Design of two prospective multicenter international trials , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[3]  P. Armstrong,et al.  Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. , 2009, Annals of internal medicine.

[4]  L. Brewster,et al.  Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. , 2008, European heart journal.

[5]  T. Nakata,et al.  Predicting the Need for an Implantable Cardioverter Defibrillator Using Cardiac Metaiodobenzylguanidine Activity Together with Plasma Natriuretic Peptide Concentration or Left Ventricular Function , 2008, Journal of Nuclear Medicine.

[6]  S. Yamashina,et al.  Neuronal imaging using SPECT , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  L. Køber,et al.  Effect of beta‐blocker therapy on functional status in patients with heart failure — A meta‐analysis , 2006, European journal of heart failure.

[8]  G. Breithardt,et al.  Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  G. Schmidt,et al.  Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction. , 2004, European heart journal.

[10]  P. Merlet,et al.  Uptake-1 carrier downregulates in parallel with the beta-adrenergic receptor desensitization in rat hearts chronically exposed to high levels of circulating norepinephrine: implications for cardiac neuroimaging in human cardiomyopathies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  M. Kurabayashi,et al.  Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[13]  T. Nakata,et al.  Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  G. Jennings,et al.  Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. , 2001, European heart journal.

[15]  S. Gerber,et al.  The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation. , 2001, Journal of molecular and cellular cardiology.

[16]  M. Hamon,et al.  Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  P. Merlet,et al.  Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  P. Merlet,et al.  Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis. , 1999, Journal of the American College of Cardiology.

[19]  T. Nakata,et al.  Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts , 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[20]  M. Schwaiger,et al.  Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. , 1998, Circulation.

[21]  M. Böhm,et al.  Evidence for reduction of norepinephrine uptake sites in the failing human heart. , 1995, Journal of the American College of Cardiology.

[22]  P. Merlet,et al.  Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  R. Candinas,et al.  Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. , 1990, Circulation.

[24]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[25]  A. Mark,et al.  Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. , 1986, Circulation.

[26]  Sisson Jc,et al.  Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies. , 1986, American journal of physiologic imaging.

[27]  J. Sisson,et al.  Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies. , 1986, American journal of physiologic imaging.

[28]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[29]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.